Molecular Formula | C25H27N3O3S |
Molar Mass | 449.57 |
Density | 1.38±0.1 g/cm3(Predicted) |
Boling Point | 771.6±60.0 °C(Predicted) |
pKa | 11.22±0.70(Predicted) |
Storage Condition | 2-8°C |
biological activity | Brexpiprazole S-oxide (DM-3411) is the main metabolite of Brexpiprazole and is metabolized by cytochrome P450 3A4 (CYP3A4). Brexpiprazole, an atypical antipsychotic, is a partial agonist of human 5-HT1A and dopamine receptors with Ki of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also an antagonist of 5-HT2A receptor, Ki is 0.47 nM. |
target | 5-HT 1A Receptor 0.12 nM (Ki) 5-HT 2A Receptor 0.47 nM (Ki) D 2 Receptor 0.3 nM (Ki) |